(Q46504064)

22 December 2017

title

Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant (English)

1 reference

22 December 2017

1 reference

Arthur J Bergman

1

1 reference

22 December 2017

Thomas Marbury

2

1 reference

22 December 2017

Trisha Fosbinder

3

1 reference

22 December 2017

Suzanne Swan

4

1 reference

22 December 2017

Lisa Hickey

5

1 reference

22 December 2017

Thomas E Bradstreet

6

1 reference

22 December 2017

John Busillo

7

1 reference

22 December 2017

Kevin J Petty

8

1 reference

22 December 2017

Kala-Jyoti Viswanathan Aiyer

9

1 reference

22 December 2017

Marvin Constanzer

10

1 reference

22 December 2017

Su-Er W Huskey

11

1 reference

22 December 2017

Anup Majumdar

12

1 reference

22 December 2017

publication date

1 January 2005

1 reference

22 December 2017

Clinical Pharmacokinetics

published in

1 reference

22 December 2017

volume

44

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

637-647

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.2165/00003088-200544060-00005

exact match

0 references

cites work

Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency

1 reference

12 December 2020

Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs

1 reference

12 December 2020

The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

1 reference

12 December 2020

Consequences of renal insufficiency on the hepatic clearance of some drugs

1 reference

12 December 2020

Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment.

1 reference

12 December 2020

Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone

1 reference

12 December 2020

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group

1 reference

12 December 2020

Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part I).

1 reference

12 December 2020

Cyclosporin: measurement of fraction unbound in plasma

1 reference

12 December 2020

The pharmacokinetics of cerivastatin in patients on chronic hemodialysis

1 reference

12 December 2020

The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil

1 reference

12 December 2020

Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

1 reference

12 December 2020

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America

1 reference

12 December 2020

Changes in plasma protein binding have little clinical relevance

1 reference

12 December 2020

Principles of drug administration in renal insufficiency

1 reference

12 December 2020

Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

1 reference

12 December 2020

Pharmacokinetics of mycophenolic acid in renal insufficiency

1 reference

12 December 2020

10.2165/00003088-200544060-00005

Identifiers

DOI

1 reference

22 December 2017

Dimensions Publication ID

1003484606

0 references

1 reference

22 December 2017